Literature DB >> 35043215

Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats.

A N Baldwin1, M L Banks1, S A Marsh1, E A Townsend1, M Venniro2, Y Shaham3, S Stevens Negus4.   

Abstract

RATIONALE: Clinically relevant pain is often associated with functional impairment and behavioral depression, including depression of social behavior. Moreover, recovery of function is a major goal in pain treatment. We used a recently developed model of operant responding for social interaction in rats to evaluate the vulnerability of social behavior to an experimental pain manipulation and the sensitivity of pain-depressed social behavior to treatment with clinically effective analgesics.
METHODS: Sprague-Dawley male and female rats were trained to lever press for social access to another rat, and responding was evaluated after treatment with (a) intraperitoneal injection of dilute lactic acid (IP acid; 0.18-5.6%) administered alone as a visceral noxious stimulus, (b) the mu-opioid receptor (MOR) agonist morphine (0.32-10 mg/kg) or nonsteroidal anti-inflammatory drug (NSAID) ketoprofen (10 mg/kg) administered alone, or (c) morphine or ketoprofen administered before IP acid. For comparison, the same treatments were evaluated in separate rats trained to lever press for food delivery.
RESULTS: Both IP acid alone and morphine alone more potently decreased responding maintained by social interaction than by food, whereas ketoprofen did not affect responding for either reinforcer. In general, analgesics were most effective to rescue operant responding when relatively low IP acid concentrations produced significant but submaximal behavioral depression; however, morphine was not effective to rescue responding for social interaction.
CONCLUSIONS: Operant responding maintained by social interaction was more sensitive to pain-related disruption and less responsive to opioid analgesic rescue than food-maintained operant responding. Social behavior may be especially vulnerable to depression by pain states.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Analgesia; Ketoprofen; Morphine; Pain; Pain-depressed behavior; Social self-administration

Mesh:

Substances:

Year:  2022        PMID: 35043215     DOI: 10.1007/s00213-021-06048-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

Review 1.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Nathaniel P Katz; Robert D Kerns; Gerold Stucki; Robert R Allen; Nicholas Bellamy; Daniel B Carr; Julie Chandler; Penney Cowan; Raymond Dionne; Bradley S Galer; Sharon Hertz; Alejandro R Jadad; Lynn D Kramer; Donald C Manning; Susan Martin; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; Wendye Robbins; James P Robinson; Margaret Rothman; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; Joachim Wernicke; James Witter
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

2.  Differential suppression of intracranial self-stimulation, food-maintained operant responding, and open field activity by paw incision and spinal nerve ligation in rats.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesth Analg       Date:  2014-04       Impact factor: 5.108

3.  Pain correlates with social integration in individuals with traumatic spinal cord injury: A cross-sectional survey.

Authors:  Wang Dawu; He Chao; Li Kaiting; Shao Lan; Peng Xiaohua; Bai Dingqun
Journal:  J Rehabil Med       Date:  2019-07-08       Impact factor: 2.912

4.  Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2014-11-18       Impact factor: 4.030

5.  Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Authors:  Katherine Cone; Janell Lanpher; Abigail Kinens; Philomena Richard; Sarah Couture; Rebecca Brackin; Emily Payne; Kylee Harrington; Kenner C Rice; Glenn W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

6.  Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain.

Authors:  N Andrews; E Legg; D Lisak; Y Issop; D Richardson; S Harper; T Pheby; W Huang; G Burgess; I Machin; A S C Rice
Journal:  Eur J Pain       Date:  2012-04       Impact factor: 3.931

7.  The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.

Authors:  Takato Hiranita; Francisco Leon; Jasmine S Felix; Luis F Restrepo; Morgan E Reeves; Anna E Pennington; Samuel Obeng; Bonnie A Avery; Christopher R McCurdy; Lance R McMahon; Jenny L Wilkerson
Journal:  Psychopharmacology (Berl)       Date:  2019-05-17       Impact factor: 4.530

8.  Intestinal ulcerogenic effect of S(+)-ketoprofen in the rat.

Authors:  F Cabré; F Fernández; M I Zapatero; A Araño; M L García; D Mauleón
Journal:  J Clin Pharmacol       Date:  1998-12       Impact factor: 3.126

Review 9.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

10.  The impact of neuropathic pain on relationships.

Authors:  S José Closs; Victoria Staples; Innes Reid; Michael I Bennett; Michelle Briggs
Journal:  J Adv Nurs       Date:  2009-02       Impact factor: 3.187

View more
  1 in total

1.  Rats choose alcohol over social reward in an operant choice procedure.

Authors:  Nathan J Marchant; Allison J McDonald; Rie Matsuzaki; Yvar van Mourik; Dustin Schetters; Taco J De Vries
Journal:  Neuropsychopharmacology       Date:  2022-09-15       Impact factor: 8.294

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.